Medical Management of Patients with an Acute Stroke: Treatment and Prevention

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Stroke is a common and serious disorder and will probably occur with increasing frequency due to an aging of the population. Acute therapies aimed at reversing the effects of acute ischemic stroke are limited to recombinant tissue plasminogen activator administered intravenously within 3 hours of stroke onset. Neuroprotective agents and acute anticoagulation with agents such as heparinoids and heparin are not effective in most cases. Poststroke medical complications such as infection and venous thromboembolism are common but are largely preventable. A variety of medical therapies such as antiplatelet agents, warfarin, statins, and ACE inhibitors can reduce the risk of a recurrent stroke. A key aspect of management for stroke is selection of the proper treatment regimen for each patient.

Original languageEnglish (US)
Pages (from-to)34-45
Number of pages12
JournalTopics in Stroke Rehabilitation
Volume10
Issue number3
DOIs
StatePublished - Sep 2003

Fingerprint

Stroke
Heparinoids
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Platelet Aggregation Inhibitors
Venous Thromboembolism
Neuroprotective Agents
Tissue Plasminogen Activator
Warfarin
Angiotensin-Converting Enzyme Inhibitors
Anticoagulants
Heparin
Infection
Population

Keywords

  • Cerebrovascular disease
  • Stroke
  • Stroke prevention
  • Stroke therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Rehabilitation

Cite this

Medical Management of Patients with an Acute Stroke : Treatment and Prevention. / Alberts, Mark J.

In: Topics in Stroke Rehabilitation, Vol. 10, No. 3, 09.2003, p. 34-45.

Research output: Contribution to journalArticle

@article{b83141c348c7447fa1cd897b7c151ba9,
title = "Medical Management of Patients with an Acute Stroke: Treatment and Prevention",
abstract = "Stroke is a common and serious disorder and will probably occur with increasing frequency due to an aging of the population. Acute therapies aimed at reversing the effects of acute ischemic stroke are limited to recombinant tissue plasminogen activator administered intravenously within 3 hours of stroke onset. Neuroprotective agents and acute anticoagulation with agents such as heparinoids and heparin are not effective in most cases. Poststroke medical complications such as infection and venous thromboembolism are common but are largely preventable. A variety of medical therapies such as antiplatelet agents, warfarin, statins, and ACE inhibitors can reduce the risk of a recurrent stroke. A key aspect of management for stroke is selection of the proper treatment regimen for each patient.",
keywords = "Cerebrovascular disease, Stroke, Stroke prevention, Stroke therapy",
author = "Alberts, {Mark J.}",
year = "2003",
month = "9",
doi = "10.1310/1QT2-J1BV-JXGN-1DWV",
language = "English (US)",
volume = "10",
pages = "34--45",
journal = "Topics in Stroke Rehabilitation",
issn = "1074-9357",
publisher = "Thomas Land Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Medical Management of Patients with an Acute Stroke

T2 - Treatment and Prevention

AU - Alberts, Mark J.

PY - 2003/9

Y1 - 2003/9

N2 - Stroke is a common and serious disorder and will probably occur with increasing frequency due to an aging of the population. Acute therapies aimed at reversing the effects of acute ischemic stroke are limited to recombinant tissue plasminogen activator administered intravenously within 3 hours of stroke onset. Neuroprotective agents and acute anticoagulation with agents such as heparinoids and heparin are not effective in most cases. Poststroke medical complications such as infection and venous thromboembolism are common but are largely preventable. A variety of medical therapies such as antiplatelet agents, warfarin, statins, and ACE inhibitors can reduce the risk of a recurrent stroke. A key aspect of management for stroke is selection of the proper treatment regimen for each patient.

AB - Stroke is a common and serious disorder and will probably occur with increasing frequency due to an aging of the population. Acute therapies aimed at reversing the effects of acute ischemic stroke are limited to recombinant tissue plasminogen activator administered intravenously within 3 hours of stroke onset. Neuroprotective agents and acute anticoagulation with agents such as heparinoids and heparin are not effective in most cases. Poststroke medical complications such as infection and venous thromboembolism are common but are largely preventable. A variety of medical therapies such as antiplatelet agents, warfarin, statins, and ACE inhibitors can reduce the risk of a recurrent stroke. A key aspect of management for stroke is selection of the proper treatment regimen for each patient.

KW - Cerebrovascular disease

KW - Stroke

KW - Stroke prevention

KW - Stroke therapy

UR - http://www.scopus.com/inward/record.url?scp=0344495251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344495251&partnerID=8YFLogxK

U2 - 10.1310/1QT2-J1BV-JXGN-1DWV

DO - 10.1310/1QT2-J1BV-JXGN-1DWV

M3 - Article

C2 - 14681818

AN - SCOPUS:0344495251

VL - 10

SP - 34

EP - 45

JO - Topics in Stroke Rehabilitation

JF - Topics in Stroke Rehabilitation

SN - 1074-9357

IS - 3

ER -